Trial Details
COMPLETEDBasic Information
| Clinical ID | c526 |
|---|---|
| Identifier | NCT02200445 |
| Trial Title | Low Dose IL-2 for Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Interleukin-2 (aldesleukin). |
Participant Information
| Sponsor | Scott B. Snapper, MD PHD |
|---|---|
| City | Boston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-02-15 |
|---|---|
| Primary Completion Date | 2020-10-01 |
| Completion Date | 2025-03-21 |